Emerging Therapeutic Targets in Ovarian Cancer

Editors: Kaye, S., Brown, R., Gabra, H., Gore, M.E. (Eds.)

  • Discusses progress in linking the biology of ovarian cancer with novel targets and innovative therapies entering clinical trials
  • Provides an up-to-date perspective on successful therapeutic developments as a partnership between laboratory-based and clinical-based research scientists
  • Identifies those areas of translational research which we believe have shown the most promise, or are likely to do so, in the treatment of ovarian cancer
see more benefits

Buy this book

eBook $199.00
price for USA (gross)
  • ISBN 978-1-4419-7216-3
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $259.00
price for USA
  • ISBN 978-1-4419-7215-6
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $259.00
price for USA
  • ISBN 978-1-4899-8233-9
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
About this book

Despite rapid advances in understanding the biology of ovarian cancer, progress in treatment has been slow. But the prospects for improvement have never been better. A wide range of novel therapeutic targets now present themselves for clinical evaluation and initial results are certainly encouraging. In this text, all these areas are covered by experts in the field. Each chapter provides up-to-date coverage of clinical information, prefaced by a description of the rational basis for the selection of each target area and consideration of biomarkers that can be used to aid clinical evaluation. The four editors work together within the Ovarian Cancer Action collaborative research programme in London and they bring a wealth of laboratory and clinical expertise to this topic. The text should provide an invaluable source of reference for clinical and laboratory-based researchers working to meet the challenges of ovarian cancer.

Table of contents (13 chapters)

  • Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs

    Banerjee, Susana (et al.)

    Pages 1-33

  • Discovery of Novel Targets

    Farley, John (et al.)

    Pages 35-50

  • Novel Anti-angiogenic Therapies in Ovarian Cancer

    Hasan, Jurjees (et al.)

    Pages 51-72

  • Targeting the AKT Pathway in Ovarian Cancer

    Stronach, Euan A. (et al.)

    Pages 73-94

  • Inhibition of the Src Oncogene: Therapeutic Potential in Ovarian Carcinoma

    Han, Liz Y. (et al.)

    Pages 95-107

Buy this book

eBook $199.00
price for USA (gross)
  • ISBN 978-1-4419-7216-3
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $259.00
price for USA
  • ISBN 978-1-4419-7215-6
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $259.00
price for USA
  • ISBN 978-1-4899-8233-9
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Emerging Therapeutic Targets in Ovarian Cancer
Editors
  • Stan Kaye
  • Robert Brown
  • Hani Gabra
  • Martin E. Gore
Copyright
2011
Publisher
Springer-Verlag New York
Copyright Holder
Springer Science+Business Media, LLC
eBook ISBN
978-1-4419-7216-3
DOI
10.1007/978-1-4419-7216-3
Hardcover ISBN
978-1-4419-7215-6
Softcover ISBN
978-1-4899-8233-9
Edition Number
1
Number of Pages
XIII, 291
Topics